Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study

Overview of attention for article published in Frontiers in oncology, July 2024

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 Reddit thread.

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.